Maternally Transmitted Opiate Abuse Vulnerability

母婴传播阿片类药物滥用的脆弱性

基本信息

  • 批准号:
    7729779
  • 负责人:
  • 金额:
    $ 28.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-07-01 至 2012-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Many studies have demonstrated that the hereditary nature of drug abuse is due to both genetic and environmental factors. Recent findings demonstrate that one mechanism regulating interactions between genes and the environment are epigenetic modifications. The term epigenetics refers to DNA and histone protein modifications that regulate gene expression and which are transmitted from a mother cell to a daughter cell or from a parent to a progeny, but which do not change the underlying DNA sequence. While it is clear that epigenetic modifications can be passed from one generation to the next, the mechanisms involved in the transmission of these effects are not fully understood. Several recent findings indicate that the maternal environment, both pre- and postnatal, may play a critical role in epigenetic transfer. To date, the role of epigenetics in familial patterns of drug abuse has not been well studied. Prescription narcotics use by adolescent females has increased dramatically in the past decade. We have developed an animal model of adolescent morphine exposure in female rats to examine the long-term consequences of opiate use during this unique developmental period. Our findings demonstrate that in addition to significant alterations in gene expression in adult female rats exposed to morphine during adolescence, the offspring of adolescent-exposed females demonstrate enhanced responsiveness to morphine. These offspring effects suggest adolescent morphine exposure increases the risk of drug abuse in the next generation. One of important aspect of this model is that adolescent morphine-exposed females are drug-free for at least 10 days prior to mating. Thus, developing offspring are never directly exposed to morphine. This means that any effect observed in the offspring is maternally-derived. The purpose of the present proposal is to determine the role of epigenetics in the long-term effects of adolescent morphine exposure on both the female and her offspring. The current proposal will identify transgenerational epigenetic modifications in the adult offspring of females exposed to morphine during adolescent development (Specific Aim 1). It will also examine possible changes in the maternal environment which may play a role in the transmission of these offspring effects (Specific Aim 2). Finally, we will test whether postnatal manipulations can ameliorate or prevent the transgenerational effects of adolescent morphine exposure (Specific Aim 3). Understanding how drug-induced alterations in morphine sensitivity may be passed from one generation to the next will help identify basic mechanisms underlying familial patterns of drug abuse as well as possible interventions. PUBLIC HEALTH RELEVANCE: The goal of this project is to understand how mothers who are exposed to narcotics during adolescence increase the probability of drug abuse in their future offspring. These studies will provide a foundation for understanding the role of maternal factors in familial patterns of drug abuse.
描述(由申请人提供):许多研究表明,药物滥用的遗传性是由遗传和环境因素造成的。最近的研究结果表明,调节基因与环境之间相互作用的一种机制是表观遗传修饰。表观遗传学一词是指调节基因表达的 DNA 和组蛋白修饰,这些修饰从母细胞传递到子细胞或从亲本传递到子代,但不会改变潜在的 DNA 序列。虽然很明显表观遗传修饰可以从一代传到下一代,但这些效应传递所涉及的机制尚不完全清楚。最近的一些研究结果表明,产前和产后的母体环境可能在表观遗传转移中发挥关键作用。迄今为止,表观遗传学在药物滥用家族模式中的作用尚未得到充分研究。过去十年中,青春期女性使用处方麻醉品的数量急剧增加。我们开发了雌性大鼠青春期吗啡暴露的动物模型,以检查在这个独特的发育时期使用阿片类药物的长期后果。我们的研究结果表明,除了在青春期暴露于吗啡的成年雌性大鼠的基因表达发生显着变化外,青少年暴露于吗啡的雌性大鼠的后代也表现出对吗啡的反应性增强。这些后代效应表明青少年接触吗啡会增加下一代药物滥用的风险。该模型的一个重要方面是,暴露于吗啡的青春期雌性在交配前至少 10 天不吸毒。因此,发育中的后代永远不会直接接触吗啡。这意味着在后代中观察到的任何影响都是母源性的。本提案的目的是确定表观遗传学在青少年吗啡暴露对女性及其后代的长期影响中的作用。目前的提案将确定青少年发育期间接触吗啡的雌性成年后代的跨代表观遗传修饰(具体目标 1)。它还将检查母体环境可能发生的变化,这些变化可能在这些后代效应的传播中发挥作用(具体目标 2)。最后,我们将测试产后处理是否可以改善或预防青少年吗啡暴露的跨代影响(具体目标 3)。了解药物引起的吗啡敏感性改变如何从一代传递到下一代将有助于确定药物滥用家族模式的基本机制以及可能的干预措施。公共卫生相关性:该项目的目标是了解青春期接触麻醉品的母亲如何增加其未来后代滥用药物的可能性。这些研究将为了解母亲因素在家庭药物滥用模式中的作用奠定基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ELIZABETH M BYRNES其他文献

ELIZABETH M BYRNES的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ELIZABETH M BYRNES', 18)}}的其他基金

An Intranasal GDNF Gene Therapy for Opioid Relapse Reduction
鼻内 GDNF 基因疗法可减少阿片类药物复发
  • 批准号:
    10154341
  • 财政年份:
    2021
  • 资助金额:
    $ 28.88万
  • 项目类别:
Oxycodone, Neonatal Opioid Withdrawal Syndrome, and Adult Abuse Liability
羟考酮、新生儿阿片类药物戒断综合征和成人滥用责任
  • 批准号:
    10226113
  • 财政年份:
    2020
  • 资助金额:
    $ 28.88万
  • 项目类别:
Oxycodone, Neonatal Opioid Withdrawal Syndrome, and Adult Abuse Liability
羟考酮、新生儿阿片类药物戒断综合征和成人滥用责任
  • 批准号:
    10625995
  • 财政年份:
    2020
  • 资助金额:
    $ 28.88万
  • 项目类别:
Oxycodone Neonatal Opioid Withdrawal Syndrome and Adult Abuse Liability
羟考酮新生儿阿片类药物戒断综合征和成人滥用责任
  • 批准号:
    10838025
  • 财政年份:
    2020
  • 资助金额:
    $ 28.88万
  • 项目类别:
Oxycodone, Neonatal Opioid Withdrawal Syndrome, and Adult Abuse Liability
羟考酮、新生儿阿片类药物戒断综合征和成人滥用责任
  • 批准号:
    10404614
  • 财政年份:
    2020
  • 资助金额:
    $ 28.88万
  • 项目类别:
Relaxin 3 and sex differences in post-stroke depression
松弛素 3 与中风后抑郁症的性别差异
  • 批准号:
    9568818
  • 财政年份:
    2017
  • 资助金额:
    $ 28.88万
  • 项目类别:
Relaxin 3 and sex differences in post-stroke depression
松弛素 3 与中风后抑郁症的性别差异
  • 批准号:
    9453969
  • 财政年份:
    2017
  • 资助金额:
    $ 28.88万
  • 项目类别:
Embryo Transfer for the Study of Transgenerational Modifications in Morphine Sens
用于吗啡敏感跨代修饰研究的胚胎移植
  • 批准号:
    8429728
  • 财政年份:
    2013
  • 资助金额:
    $ 28.88万
  • 项目类别:
Embryo Transfer for the Study of Transgenerational Modifications in Morphine Sens
用于吗啡敏感跨代修饰研究的胚胎移植
  • 批准号:
    8601067
  • 财政年份:
    2013
  • 资助金额:
    $ 28.88万
  • 项目类别:
Sex Differences in Adolescent Exposure to Morphine on Reward Related Behaviors in Subsequent Offspring
青少年接触吗啡对后代奖励相关行为的性别差异
  • 批准号:
    8994484
  • 财政年份:
    2009
  • 资助金额:
    $ 28.88万
  • 项目类别:

相似国自然基金

亲子互动多维同步性对青少年感恩品德发展的影响:人际与个体内部机制
  • 批准号:
    32300912
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
儿童青少年睡眠与昼夜节律紊乱对特发性脊柱侧凸发生发展的影响
  • 批准号:
    82302783
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
青少年游戏成瘾的发展与脑神经机制研究
  • 批准号:
    32300887
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
人际压力影响青少年抑郁发展的心理与神经机制:基于自我意识的视角
  • 批准号:
    32371118
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
视网膜图像病变自动检测与青少年近视发展风险预测技术研究
  • 批准号:
    62301330
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
  • 批准号:
    10751106
  • 财政年份:
    2024
  • 资助金额:
    $ 28.88万
  • 项目类别:
Identification of Prospective Predictors of Alcohol Initiation During Early Adolescence
青春期早期饮酒的前瞻性预测因素的鉴定
  • 批准号:
    10823917
  • 财政年份:
    2024
  • 资助金额:
    $ 28.88万
  • 项目类别:
Parent-adolescent informant discrepancies: Predicting suicide risk and treatment outcomes
父母与青少年信息差异:预测自杀风险和治疗结果
  • 批准号:
    10751263
  • 财政年份:
    2024
  • 资助金额:
    $ 28.88万
  • 项目类别:
Early Life Stress Induced Reprogramming of Vascular Function by the Endothelium and Macrophage Systems
生命早期的压力诱导内皮细胞和巨噬细胞系统对血管功能进行重新编程
  • 批准号:
    10555125
  • 财政年份:
    2023
  • 资助金额:
    $ 28.88万
  • 项目类别:
Neurodevelopment of executive function, appetite regulation, and obesity in children and adolescents
儿童和青少年执行功能、食欲调节和肥胖的神经发育
  • 批准号:
    10643633
  • 财政年份:
    2023
  • 资助金额:
    $ 28.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了